Study details
Enrolling now
Memantine and Exercise to Improve Cognitive Function
UNC Lineberger Comprehensive Cancer Center
NCT IDNCT06727773ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
90
Study length
about 3.5 years
Ages
18+
Sex
Female only
Locations
1 site in NC
About this study
Researchers are testing whether memantine and exercise can improve cognitive function in breast cancer patients undergoing chemotherapy. The trial will evaluate the feasibility, acceptability, and preliminary efficacy of a combination treatment with memantine and an exercise program on cognitive decline and related biomarkers.
Based on ClinicalTrials.gov records.
What participants do
- 1.Exercise Control
- 2.Exercise Intervention
- 3.Take Memantine
- +1 more
PhasePhase 2
DrugMemantine
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
memantine
Body systems
Oncology